The CDC is expected to meet later in the month to adopt vaccine recommendations for older Americans.
mRNA COVID-19 vaccine less protective in elderly with comorbidity
Dec 23, 2021
At ≥7 days after the second dose, the effectiveness of mRNA COVID-19 vaccine was 69% against infection and 86% against related death.
mRNA COVID-19 vaccines immunogenic in immunosuppressed patients
Sep 08, 2021
mRNA-based severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines appear to be immunogenic in patients receiving immunosuppressive medications for the management of chronic inflammatory...
Immune response not inferior with coadministration of COVID-19, flu shots
Sep 14, 2023
A similar immune response and no increase in the rate of reactogenicity events was seen with coadministration versus administering the COVID-19 vaccine alone.
COVID-19 vaccination may increase risk for urinary tract symptoms
Aug 01, 2024
A higher proportion of those who received a single dose versus three doses had to urinate five or more times in the night.
Review of booster shots for Moderna, J&J vaccines just weeks away: Fauci
Sep 20, 2021
Fauci says that data on booster shots for those vaccines are only a few weeks away from a review by the FDA.
ACR: Lupus patients can have low immune response to COVID-19 vaccines
Nov 15, 2021
Overall disease activity does not appear to change after vaccination, however.
Adverse events associated with BNT162b2 vaccination ID’d
Aug 27, 2021
Vaccination with the Pfizer–BioNTech mRNA vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is associated with an increased risk for myocarditis and lymphadenopathy, according...
Flu vaccine uptake varies by sociodemographic factors in CKD patients
Sep 26, 2023
Just under three-quarters of patients with chronic kidney disease receive flu vaccines
Reformulated booster shots ready by September, White House says
Jul 29, 2022
The Biden administration is working on contracts for the reformulated booster doses.